131 related articles for article (PubMed ID: 10386405)
1. Result of induction chemotherapy followed by surgery in patients with stage IIIA N2 NSCLC: importance of pre-treatment mediastinoscopy.
De Leyn P; Vansteenkiste J; Deneffe G; Van Raemdonck D; Coosemans W; Lerut T
Eur J Cardiothorac Surg; 1999 May; 15(5):608-14. PubMed ID: 10386405
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience.
Lorent N; De Leyn P; Lievens Y; Verbeken E; Nackaerts K; Dooms C; Van Raemdonck D; Anrys B; Vansteenkiste J;
Ann Oncol; 2004 Nov; 15(11):1645-53. PubMed ID: 15520066
[TBL] [Abstract][Full Text] [Related]
3. Vindesine-ifosfamide-platinum (VIP) induction chemotherapy in surgically staged IIIA-N2 non-small-cell lung cancer: a prospective study. Leuven Lung Cancer Group.
Vansteenkiste JF; De Leyn PR; Deneffe GJ; Lievens YN; Nackaerts KL; Van Raemdonck DE; van der Schueren E; Lerut TE; Demedts MG
Ann Oncol; 1998 Mar; 9(3):261-7. PubMed ID: 9602259
[TBL] [Abstract][Full Text] [Related]
4. Outcome of Patients With pN2 "Potentially Resectable" Nonsmall Cell Lung Cancer Who Underwent Surgery After Induction Chemotherapy.
Spaggiari L; Casiraghi M; Guarize J; Brambilla D; Petrella F; Maisonneuve P; De Marinis F
Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):593-602. PubMed ID: 28043483
[TBL] [Abstract][Full Text] [Related]
5. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
Nagai K; Tsuchiya R; Mori T; Tada H; Ichinose Y; Koike T; Kato H;
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):254-60. PubMed ID: 12579093
[TBL] [Abstract][Full Text] [Related]
7. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
Li J; Dai CH; Yu LC; Chen P; Li XQ; Shi SB; Wu JR
Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
[TBL] [Abstract][Full Text] [Related]
8. [Surgical treatment of non-small cell lung cancer with mediastinal node invasion. A retrospective study].
Arnau Obrer A; Martín Díaz E; Pérez Alonso D; Regueiro Mira F; Cervera Juan A; Granell Gil M; Roch Pendería S; Cantó Armengod A
Arch Bronconeumol; 2001 Mar; 37(3):121-6. PubMed ID: 11333537
[TBL] [Abstract][Full Text] [Related]
9. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer.
Choi NC; Carey RW; Daly W; Mathisen D; Wain J; Wright C; Lynch T; Grossbard M; Grillo H
J Clin Oncol; 1997 Feb; 15(2):712-22. PubMed ID: 9053497
[TBL] [Abstract][Full Text] [Related]
10. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study.
De Leyn P; Stroobants S; De Wever W; Lerut T; Coosemans W; Decker G; Nafteux P; Van Raemdonck D; Mortelmans L; Nackaerts K; Vansteenkiste J
J Clin Oncol; 2006 Jul; 24(21):3333-9. PubMed ID: 16849747
[TBL] [Abstract][Full Text] [Related]
11. Repeat mediastinoscopy in all its indications: experience with 96 patients and 101 procedures.
Call S; Rami-Porta R; Obiols C; Serra-Mitjans M; Gonzalez-Pont G; Bastús-Piulats R; Quintana S; Belda-Sanchis J
Eur J Cardiothorac Surg; 2011 Jun; 39(6):1022-7. PubMed ID: 21112217
[TBL] [Abstract][Full Text] [Related]
12. The impact of residual multi-level N2 disease after induction therapy for non-small cell lung cancer.
Sawabata N; Keller SM; Matsumura A; Kawashima O; Hirono T; Osaka Y; Maeda H; Fukai S; Kawahara M;
Lung Cancer; 2003 Oct; 42(1):69-77. PubMed ID: 14512190
[TBL] [Abstract][Full Text] [Related]
13. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
14. A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903).
Katakami N; Tada H; Mitsudomi T; Kudoh S; Senba H; Matsui K; Saka H; Kurata T; Nishimura Y; Fukuoka M
Cancer; 2012 Dec; 118(24):6126-35. PubMed ID: 22674529
[TBL] [Abstract][Full Text] [Related]
15. A preoperative alternating chemotherapy and radiotherapy program for patients with stage IIIA (N2) non-small cell lung cancer.
Takamori S; Rikimaru T; Hayashi A; Tayama K; Mitsuoka M; Fujimoto K; Horiuchi M; Hayabuchi N; Oizumi K; Shirouzu K
Lung Cancer; 2000 Jul; 29(1):49-56. PubMed ID: 10880847
[TBL] [Abstract][Full Text] [Related]
16. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival.
Bueno R; Richards WG; Swanson SJ; Jaklitsch MT; Lukanich JM; Mentzer SJ; Sugarbaker DJ
Ann Thorac Surg; 2000 Dec; 70(6):1826-31. PubMed ID: 11156079
[TBL] [Abstract][Full Text] [Related]
17. Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy.
Voltolini L; Luzzi L; Ghiribelli C; Paladini P; Di Bisceglie M; Gotti G
Eur J Cardiothorac Surg; 2001 Dec; 20(6):1106-12. PubMed ID: 11717012
[TBL] [Abstract][Full Text] [Related]
18. Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N2 non-small-cell lung cancer: a prospective pilot study. The Leuven Lung Cancer Group.
Vansteenkiste JF; Stroobants SG; De Leyn PR; Dupont PJ; Verbeken EK
Ann Oncol; 1998 Nov; 9(11):1193-8. PubMed ID: 9862049
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
[TBL] [Abstract][Full Text] [Related]
20. Present status of induction treatment in stage IIIA-N2 non-small cell lung cancer: a review. The Leuven Lung Cancer Group.
Vansteenkiste J; De Leyn P; Deneffe G; Menten J; Lerut T; Demedts M
Eur J Cardiothorac Surg; 1998 Jan; 13(1):1-12. PubMed ID: 9504724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
